Author

Rodrigo E. Mendes

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Aztreonam-avibactam Activity against Enterobacterales from Asia Pacific and Latin American Medical Centres: Summary of 5 years of Surveillance prior to Clinical Use (2020-2024).

OBJECTIVES To assess the in vitro activity of aztreonam-avibactam against Enterobacterales from the Asia Pacific region (APAC) and Latin America (LATAM) during a 5-year period prior to its approval for clinical use in these regions. METHODS 12,039 Enterobacterales isolates were consecutively collected in 2020-2024 fr...

H. Sader, Rodrigo E. Mendes, J. Kimbrough et al. · International Journal of Ant... · 0 citations

Open access Aug 2026

Activity of Aztreonam-avibactam and Ceftazidime-Avibactam against Enterobacterales and Pseudomonas aeruginosa causing infections in patients hospitalized in hematology, oncology, and transplant units from United States medical centres (2019-2024).

The antimicrobial susceptibility of Enterobacterales and Pseudomonas aeruginosa from patients hospitalized in hospital units where the frequency of immunosuppressed patients is very high is evaluated.

H. Sader, M. Castanheira, Todd Riccobene et al. · Diagnostic microbiology and... · 0 citations

Open access Aug 2026

In vitro activity of cefiderocol against highly resistant Gram-negative pathogens collected in the SENTRY Surveillance Program between 2020 and 2024.

OBJECTIVES This study investigated the in vitro activity of cefiderocol and comparator antibiotics against Gram-negative bacterial isolates with highly resistant phenotypes collected in the SENTRY Antimicrobial Surveillance Program. METHODS Between 2020 and 2024, consecutive Gram-negative bacterial isolates were coll...

B. DeJonge, C. Longshaw, Frank H Kung et al. · Journal of Global Antimicrob... · 1 citation